GSK in talks to buy cancer biotech Nuvalent for more than $9bn
RSS SUMMARY · AGGREGATED FROM FT
A deal will rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year
A deal will rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year
A deal will rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year
Continue Reading
The full story continues on Financial Times.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
FT
Business
Apollo and Blackstone raise $35bn in chip financing deal for Anthropic
FT·3h ago·3 min read
Business
OpenAI files to go public in blockbuster listing
FT·5h ago·3 min read
Business
Apple unveils long-awaited AI Siri after years of delays
FT·6h ago·3 min read
Business
Trump’s $100,000 H-1B visa fee blocked by judge
FT·7h ago·3 min read
Related
On this beat
Business
China’s Exports Gain Momentum; Import Growth Picks Up
TWSJ·13m ago·3 min read
Business
Google’s new feature comes with a catch
THE STREET·1h ago·3 min read
Business
The Surprising Reason Why Coca-Cola and Pepsi Are Obsessed With Mini Cans Right Now
INC·46m ago·3 min read
Business
A New Front Is Opening in the Fight to Break China’s Rare-Earth Dominance
TWSJ·1h ago·3 min read